Human Adipose Tissue-Derived Mesenchymal Stem Cells 
Alleviate Atopic Dermatitis via Decreased Serum Level of 
IgE and Number of Mast Cells

Yeganeh Davoudi; Minoo Mahmoodi; Masoud Ghorbani; Mohammad Ali Nilforoushzade; Rahim Ahmadi

Human Adipose Tissue-Derived Mesenchymal Stem Cells Alleviate Atopic Dermatitis via Decreased Serum Level of IgE and Number of Mast Cells

Abstract

Yeganeh Davoudi, Minoo Mahmoodi*, Masoud Ghorbani, Mohammad Ali Nilforoushzade and Rahim Ahmadi

Atopic dermatitis (AD) is a major inflammatory skin disease. Most patients with atopic dermatitis have elevated serum levels of mast cells and IgE. Mesenchymal stem cell (MSC) has been applied for the therapy of allergic disorders due to its beneficial immunomodulatory abilities. We sought to investigate the safety and the efficacy of human adipose tissue-derived MSCs (hAT-MSCs) in mouse atopic dermatitis (AD) model and to determine the serum levels of mast cells (MC) and IgE after subcutaneous administration

PDF

Share this article